Login / Signup

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.

Chewei Anderson ChangJayu JenShaowen JiangAzin SayadArvind Singh MerKevin R BrownAllison M L NixonAvantika DhabariaKwan Ho TangDavid VenetChristos SotiriouJiehui DengKwok-Kin WongSylvia AdamsPeter MeynAdriana HeguyJane A SkokAristotelis TsirigosBeatrix UeberheideJason MoffatAbhyudai SinghBenjamin Haibe-KainsAlireza Khodadadi-JamayranBenjamin G Neel
Published in: Cancer discovery (2022)
DTPs are implicated in resistance to anticancer therapies, but their ontogeny and vulnerabilities remain unclear. We find that HER2 TKI-DTPs emerge from stochastically arising primed cells ("pre-DTPs") that engage either of two distinct transcriptional programs upon TKI exposure. Our results provide new insights into DTP ontogeny and potential therapeutic vulnerabilities. This article is highlighted in the In This Issue feature, p. 873.
Keyphrases